- Home
- Publications
- Publication Search
- Publication Details
Title
Conditional Survival in de novo Metastatic Urothelial Carcinoma
Authors
Keywords
Cancer treatment, Cancer detection and diagnosis, Carcinomas, Bladder, Differentiated tumors, Metastasis, Bladder cancer, Hispanic people
Journal
PLoS One
Volume 10, Issue 8, Pages e0136622
Publisher
Public Library of Science (PLoS)
Online
2015-08-27
DOI
10.1371/journal.pone.0136622
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized phase II trial of maintenance sunitinib versus placebo following response to chemotherapy (CT) for patients (pts) with advanced urothelial carcinoma (UC).
- (2017) Petros Grivas et al. JOURNAL OF CLINICAL ONCOLOGY
- Post-treatment prognostic model for patients (pts) with metastatic urothelial cancer (UC) treated with first-line chemotherapy.
- (2017) Matt D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimizing Systemic Therapy for Bladder Cancer
- (2017) Sumanta K. Pal et al. Journal of the National Comprehensive Cancer Network
- Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy
- (2013) Matthew D. Galsky et al. CANCER
- Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time
- (2013) Guillaume Ploussard et al. EUROPEAN UROLOGY
- Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study
- (2012) Lauren C Harshman et al. LANCET ONCOLOGY
- Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy
- (2011) Maxine Sun et al. EUROPEAN JOURNAL OF CANCER
- The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen
- (2011) Tatsuo Gondo et al. International Journal of Clinical Oncology
- Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75
- (2011) Noah M. Hahn et al. JOURNAL OF CLINICAL ONCOLOGY
- A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy
- (2011) Matthew D Galsky et al. LANCET ONCOLOGY
- Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urothelium
- (2010) Guru Sonpavde et al. LANCET ONCOLOGY
- A Phase II Study of Docetaxel and Oxaliplatin for Second-Line Treatment of Urothelial Carcinoma
- (2009) Sandy Srinivas et al. CHEMOTHERAPY
- Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract
- (2009) Joaquim Bellmunt et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802)
- (2008) Robert Dreicer et al. CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started